Patent details

Basic Information

Publication number:

EP2103307

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Revoked

Application number:

EP091643791

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

Methylphenidate modified release formulations

French Title of Invention:

Formulations de libération modifiée de méthylphénidate

German Title of Invention:

Methylphenidatformulierungen mit modifizierter Freisetzung

SPC Number:

Dates

Filing date:

09/10/2001

Grant date:

07/12/2016

EP Publication Date:

07/12/2016

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

23/09/2009

EP B1 Publication Date:

07/12/2016

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

09/10/2021

Renunciation date:

Revocation date:

02/10/2020

Annulment date:

Owner

From:

20/09/2017

 

 

Name:

Shire Pharmaceuticals Ireland Limited

Address:

Block 2 & 3 Miesian Plaza, 50 & 58 Baggot Street Lower, Dublin 2, Ireland (IE)

History of Owners

From:

09/10/2001

To:

17/03/2017

Name:

Shire Pharmaceuticals Ireland Limited

Address:

5 Riverwalk Citiwest Business Campus, Dublin 24, Ireland (IE)

Agent

Name:

Office FREYLINGER S.A.

From:

01/03/2017

Address:

PO Box 48, 8001, STRASSEN, Luxembourg (LU)

To:

Inventor

1

Name:

Venkatesh Gopi M

Address:

United States (US)

2

Name:

Bettman Marie J

Address:

United States (US)

3

Name:

Percel Phillip J

Address:

United States (US)

4

Name:

Vishnupad Krishna S

Address:

United States (US)

5

Name:

Hensley Dan L

Address:

United States (US)

Priority

Priority Number:

697803

Priority Date:

27/10/2000

Priority Country:

United States (US)

Classification

Main IPC Class:

A61K 31/4458;

Publication

Bulletin

1

Bulletin Heading:

CO

Bulletin edition number:

2017/06

Publication date:

10/10/2017

Description:

Section M : Transfers of property (Art. 53 of the law), change of name and/or address

2

Bulletin Heading:

VRV

Bulletin edition number:

2021/01

Publication date:

05/01/2021

Description:

Section L: Applications for patents or supplementary protection certificates which have been withdrawn or are deemed to have been withdrawn (art. 32, 35.1, 39.5 of the law) Renunciation to a patent or supplementary protection certificate (Art. 72 of the law) Rejected applications for extensions for pediatric use of supplementary protections certificates

European Patent Bulletin

1

Issue number:

201709

Publication date:

01/03/2017

Description:

Document reprinted after correction (B8, B9)

2

Issue number:

201716

Publication date:

19/04/2017

Description:

Transfer of Rights

3

Issue number:

202053

Publication date:

30/12/2020

Description:

Revocation of the European patent

Deed

Change of owner(s)

Change Kind/ Decision Type:

Change of owner(s) name/address

Deed Number:

RC20170000350A

Date Registered:

20/09/2017

Licence Effective Date:

Licence Expiration Date:

Scope of Licence:

Deed Filer:

OFFICE FREYLINGER S.A.

Journal Edition Number:

Text:

Change of address

Country Code:

Updated Licence Number:

Terminated Licence Number:

Added Owner(s)

Name:

Shire Pharmaceuticals Ireland Limited

Address:

Block 2 & 3 Miesian Plaza, 50 & 58 Baggot Street Lower, Dublin 2, Ireland (IE)

Removed Pledgee

Name:

Address:

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

22/09/2020

Last Annual Fee Paid Number:

20

Last Annual Fee Paid Amount:

300 Euro

Payer:

ANAQUA SERVICES (ANC. SGA2)

Filing date	Document type	Number of pages
20/09/2017	Request For Change	1
01/03/2017	Power Of Attorney	1
21/09/2017	Outgoing Correspondence	1
07/03/2018	Incoming Correspondence (Post)	7